ArticleScientific reports2025
Carbon dot based molecularly imprinted polymer for selective fluorometric determination of tetracycline and metronidazole in pharmaceuticals and human plasma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A highly sensitive, selective, and rapid spectrofluorometric method has been developed using fluorescence sensors. This method is based on the highly fluorescent graphene quantum dots coated with silica molecularly imprinted polymers (GQDs-SMIPs) for the determination of tetracycline HCl (TET) and metronidazole (MET). Upon excitation of the GQDs-SMIPs at 260.0 nm for TET and 245.0 nm for MET, strong fluorescence emissions at 292.0 nm were produced for both sensors. Such fluorescence was quenched by the addition of their corresponding molecularly imprinted polymer (MIPs) templates. The quenching effect was linear over the concentration ranges of 15.0-120.0 µM and 15.0-140.0 µM for TET and MET, respectively. Limits of detection (LOD) were 3.55 µM, and 4.48 µM while limits of quantification (LOQ) were 10.75 µM and 13.57 µM for TET and MET, respectively. The fabricated GQDs-SMIPs were characterized using scanning electronic microscopy, Fourier-transform IR spectroscopy, and X-ray diffraction. Selectivity of the method was investigated against potentially interfering substances, including two official impurities of TET and MET. Additionally, this fluorescent technique was successfully applied for the determination of these drugs in pharmaceutical dosage forms and spiked human plasma samples. This approach provides a selective and sensitive fluorometric platform for the determination of the studied drugs in complex matrices and quality control laboratories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.